News and Events
Highlights at NanoView Biosciences including news and conferences attended.
ExoView R100 Awarded SLAS 2019 New Product Award
NanoView Biosciences is one of three winners of the SLAS 2019 New Product Award!
NanoView product workshop at the GSEV meeting in Frankfurt
NanoView will be showcasing the ExoView™ platform at the upcoming GSEV meeting in Frankfurt (March 7th - 8th). Dr George Daaboul will be giving a technical presentation of the technology, as well as running a technology workshop on March 9th.
ExoView Platinum Sponsors at ISEV 2019 in Kyoto
We’ll be showcasing the ExoView Platform at the upcoming ISEV 2019 meeting in Kyoto. We will have some more exciting news soon!
ExoView Product Launch at SLAS 2019
NanoView Biosciences launches the ExoView platform for reliable exosome biomarker characterization at SLAS 2019.
NanoView Completes $10 Million Series B Financing
Funding to support commercialization of ExoView™ system
NanoView Awarded Phase II SBIR Grant from the National Science Foundation
NanoView Biosciences Appoints Jerry Williamson as Chief Executive Officer
The German Society for Extracellular Vesicles (GSEV 2018), Frankfurt, Germany, 1-2 March 2018. NanoView Biosciences will be exhibiting our ExoView platform
2018 ISEV Workshop Membranes and Extracellular Vesicles, Baltimore, USA, 24 -25 March 2018. NanoView Biosciences will be exhibiting our ExoView platform
The goal of the Workshop is to foster interactions of EV scientists with membrane biologists and engineers who may or may not have a current EV research program...and prepare one or more publications to move the field forward.
1) Fission and secretion
2) Uptake and fusion
3) Technologies to target EV membranes and membrane proteins
4) EV transfer: function and functional assays
Circulating Biomarkers World Congress, Boston, USA, 26 - 29 March, 2018
Dr George Daaboul presenting NanoView Biosciences & exhibiting NanoView's ExoView platform
Select Biosciences Fifth Annual Circulating Biomarkers World Congress 2018 brings together the most up-to-date technologies and advances in this expanding and evolving field. Our coverage in this conference focuses on the various classes of circulating biomarkers and their emerging applications:Extracellular Vesicles (EVs): Exosomes and MicrovesiclesCirculating Nucleic Acids: Circulating Cell-Free DNA, Circulating RNAsCirculating Cells in the Circulation (Circulating Tumor Cells and Cancer Stem Cells)
ISEV2018 Meeting: International Society of Extracellular Vesicles, Spain, Barcelona, 2-6th of May. NanoView Biosciences will be exhibiting our ExoView platform
The International Society for Extracellular Vesicles is the is the premier international conference of extracellular vesicle research, covering the latest in exosomes, microvesicles and more. With an anticipated 1,000 attendees, ISEV2018 will feature presentations from the top researchers in the field, as well as providing opportunities for talks from students and early career researchers.
Keystone Symposia: Exosomes/Microvesicles: Heterogeneity, Biogenesis, Function and Therapeutic Developments, Colorado, USA, June 4 - 8
NanoView Biosciences will be exhibiting our ExoView platform
The overall goal is to deepen our understanding of the structural and functional complexity of extracellular vesicles, their biogenesis and function in health and disease, cargo enrichment, potential as ideal biomarkers, and breakthroughs in their use as therapeutic targets/agents.
Exosomes & Liquid Biopsies Europe 2018, Rotterdam, The Netherlands
24 to 26 October, 2018, Dr George Daaboul presenting NanoView Biosciences & exhibiting NanoView's ExoView platform
This Exosomes and Liquid Biopsies 2018 Conference focuses primarily on biofluid-based molecular biomarkers, such as circulating tumor DNA (ctDNA) as well as circulating tumor cells (CTCs), protein-based circulating biomarkers, and exosomes/extracellular vesicles (EVs). There is much interest in the potential of ctDNA and EVs for developing biological fluid-based biopsies (such as using plasma, urine, or other biofluids) and the presenters in this conference bring together the most up-to-date information and current state-of-the-field.
The conference further explores the potential of various minimally-invasive circulating biomarker classes, such as circulating-free DNA (cfDNA), CTCs, and Extracellular Vesicles (EVs), for development of novel diagnostics for early patient monitoring.
Another component of this conference is the exploration of the science behind Exosomes and Extracellular Vesicles -- Diagnostic and Therapeutic Potential